At 9:19AM, the S&P BSE Sensex is trading at 27,417 up 14 points, while NSE Nifty is trading at 8,250 up 3 points.
The BSE Mid-cap Index and BSE Small-cap Index was trading flat.
Healthcare, Metal, Realty, Power, Banking, FMCG, Oil and gas indices are the gainers, while Auto, Consumer Durables, Capital Goods, IT, Teck indices are losers.
GAIL, BHEL, COALINDIA,SUNPHARMA,TATASTEEL, Reliance, Hindalco are among the gainers, whereas HDFC Bank, Infosys, Axis Bank, HUL are losing sheen on BSE.
US stocks were lower. The Dow Jones dropped 0.3% while S&P 500 fell half a percent. Nasdaq lost around d 0.6%.
Asian markets too are seeing profit-taking. Hong Kong's Hang Seng index is flat while China's Shanghai index is in the red.
The activity in China's factory sector shrank for the first time in seven months in December, according to reports.The final HSBC/Markit Purchasing Managers' Index (PMI) for December came in at 49.6, just below the 50.0 level.
Finance minister Arun Jaitley has set the record straight stating that his views need not be regarded as a criticism of the RBI or its governor. Meanwhile, in a report RBI has said, "latest projections suggest that CPI (Consumer Price Index) inflation over the next 12 months may hover around 6% if the international crude prices remain around the current levels and the monsoon next year turns out to be normal". The statement is seen as an indication that RBI may choose to give considerable time before lowering its policy rates.
Wockhardt, Cadila Healthcare and Hospira are reportedly voluntarily recalling certain lots of drugs in the US, according to the US Food and Drug Administration (USFDA). Lupin has received tentative approval from the US health regulator to market a generic version of Prezista tablets, used in treating HIV infection.
Hindustan Unilever sold its erstwhile headquarters Lever House at Churchgate in south Mumbai to its current tenant, Housing Development Finance Corporation, for around Rs 300 crore.
Zuari group has decided to buy more shares of Mangalore Chemicals & Fertilizers (MCF) through the proposed open offer.
The BSE Mid-cap Index and BSE Small-cap Index was trading flat.
Healthcare, Metal, Realty, Power, Banking, FMCG, Oil and gas indices are the gainers, while Auto, Consumer Durables, Capital Goods, IT, Teck indices are losers.
GAIL, BHEL, COALINDIA,SUNPHARMA,TATASTEEL, Reliance, Hindalco are among the gainers, whereas HDFC Bank, Infosys, Axis Bank, HUL are losing sheen on BSE.
US stocks were lower. The Dow Jones dropped 0.3% while S&P 500 fell half a percent. Nasdaq lost around d 0.6%.
Asian markets too are seeing profit-taking. Hong Kong's Hang Seng index is flat while China's Shanghai index is in the red.
The activity in China's factory sector shrank for the first time in seven months in December, according to reports.The final HSBC/Markit Purchasing Managers' Index (PMI) for December came in at 49.6, just below the 50.0 level.
Finance minister Arun Jaitley has set the record straight stating that his views need not be regarded as a criticism of the RBI or its governor. Meanwhile, in a report RBI has said, "latest projections suggest that CPI (Consumer Price Index) inflation over the next 12 months may hover around 6% if the international crude prices remain around the current levels and the monsoon next year turns out to be normal". The statement is seen as an indication that RBI may choose to give considerable time before lowering its policy rates.
Wockhardt, Cadila Healthcare and Hospira are reportedly voluntarily recalling certain lots of drugs in the US, according to the US Food and Drug Administration (USFDA). Lupin has received tentative approval from the US health regulator to market a generic version of Prezista tablets, used in treating HIV infection.
Hindustan Unilever sold its erstwhile headquarters Lever House at Churchgate in south Mumbai to its current tenant, Housing Development Finance Corporation, for around Rs 300 crore.
Zuari group has decided to buy more shares of Mangalore Chemicals & Fertilizers (MCF) through the proposed open offer.
No comments:
Post a Comment